Pourbakhsh Mehdi, Jabraili Masoud, Akbari Morteza, Jaymand Mehdi, Jahanban Esfahlan Rana
Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Mater Today Bio. 2025 Apr 2;32:101727. doi: 10.1016/j.mtbio.2025.101727. eCollection 2025 Jun.
Pluronics or poloxamers are a type of triblock copolymer. These non-ionic molecules consist of a hydrophobic block embedded in two hydrophilic parts. Pluronics have become favorite materials for use in the field of biomedical research due to having favorable physicochemical and biological properties such as amphiphilicity, solubility in ionic and non-ionic solutions, biocompatibility, biodegradability, self-assembly and low toxicity. The scope of these applications can vary from tissue engineering to drug delivery. One of the important uses of pluronics is to deliver drugs to various cancer cells. Herein we first provide an overview on variety of ploronic biomaterials. And then intensively evaluate their potential as drug delivery systems (DDSs) for treatment of solid tumors with special focus on breast cancers. After explaining the pros and cons of pluronics, the current status in clinical settings and future prospects are highlighted.
普朗尼克(Pluronics)或泊洛沙姆(poloxamers)是一种三嵌段共聚物。这些非离子分子由嵌入两个亲水性部分之间的疏水性嵌段组成。由于具有两亲性、在离子和非离子溶液中的溶解性、生物相容性、生物降解性、自组装性和低毒性等良好的物理化学和生物学特性,普朗尼克已成为生物医学研究领域中备受青睐的材料。这些应用的范围可以从组织工程到药物递送。普朗尼克的重要用途之一是将药物递送至各种癌细胞。在此,我们首先概述各种普朗尼克生物材料。然后深入评估它们作为治疗实体瘤,尤其是乳腺癌的药物递送系统(DDSs)的潜力。在解释了普朗尼克的优缺点之后,突出了其在临床环境中的现状和未来前景。
Mater Today Bio. 2025-4-2
Adv Colloid Interface Sci. 2022-1
Acta Biomater. 2020-7-1
Recent Pat Nanotechnol. 2025
Molecules. 2021-6-12
Pharmaceutics. 2019-12-10
Mol Pharm. 2014-8-4
Heliyon. 2017-8-30
Photochem Photobiol. 2003-3
Curr Drug Targets. 2015
Mater Today Bio. 2025-3-1
Int J Mol Sci. 2024-7-9
Br J Cancer. 2024-11
Asian Pac J Cancer Prev. 2024-4-1